chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Pt has a set back in rehabilitation. Pt was unable  to stand w/out 2 person assist, unable to shower self, dress self. or put in her hearing aids. Unable to perform task she was able to do before the vaccine dose. She had periods of staring and slow response to staff.
Nosebleeds with elevated blood pressure began at 7:00 am on February 14, took 45 minutes to control at home, 2nd nosebleed February 15 at 5:00 am took 45 minutes to stop at home, saw PCP at 10:00 am, referred to ENT, February 16 nosebleed at 5:00 am, went to ER at 8:00 am, applied Afrin and TXA, February 17 Midnight nosebleed back in ER at 1:00 AM, silver nitrate used to cauterize 2 spots on right side of nose, February 17 10:00 PM nosebleed stopped after 45 minutes starting bleeding again at 1:00 AM went to ER recauterized one spot. February 18 appointment with ENT cauterized several areas with silver nitrate, February 21 10PM nosebleed again went to ER per ENT instructions, stopped bleeding, they put in afrin, got home Februray 22 1:00 AM bleeding started again applied afrin and pressure, stopped 30 minutes later.  Appt with PCP February 22 at 10:00 am
03/01 DATE OF VACCINE; 03/03 SWEATING & CHILLS; CLIENT TOOK TYLENOL; 03/13 ARM AND HAND SWELLING 03/16 PCP VISIT; RX STERIOD SHOT & ANTIBIOTICS; 03/16 REPORTED TO HD.
rash, swollen lips, wheezing 20-30 mins p/vax; tx w/DPH & Epi; dx severe anaphylactic reaction;
Woken up by pain in jaw and center of chest at approximately 2:24 Am. Took 1 aspirin and pain dissipated within an hour.
Fever- 1 day, Sharp pain in muscle and shot site, Red Skin rash on front upper arm from shoulder to elbow - 3 Days. Took Benedryl, 7 nites , events seemed to go away on their own.
Initial information was received from a healthcare professional on 02 January 2014. This case concerns pregnant women of unknown age whose medical history and concomitant medication was not reported received two ADACEL vaccines 24 weeks apart (dose, route, form, frequency, batch number and anatomical site of administration not reported). Last menstrual period, gestational period and expected date of delivery not reported.
This case was reported by a healthcare professional via a representative and described the occurrence of swollen lips in a child male subject who was vaccinated with PEDIARIX, (GlaxoSmithKline).  Concurrent vaccination given on the same date as PEDIARIX included meningitis vaccine (unknown manufacturer).  In 2008 (approximately two months prior to reporting) the subject received 1st dose of PEDIARIX at 0.5 ml.  At an unspecified time after vaccination with PEDIARIX, the subject experienced swollen lips, hives and trouble breathing.  At the time of reporting the events were resolved.  The healthcare professional considered the events were possibly related to vaccination with PEDIARIX.
While patient recouping from knee replacement surgery, he lost control of his legs, causing a fall. He was taken to Hospital. It was then determined that he has pneumonia. Over the following 24 hours, Guillain Barre Syndrome set in causing complete paralysis.  Intravenous immunoglobulin was administered at Hospital the following week. Patient has since been transferred to another hospital and is still under treatment.
It was reported that a 20 year old female patient received a JE-VAX vaccination on 04/17/01. Reportedly on 04/20/01, the patient developed fine rash over the entire body. A physician evaluated the patient and treated her with Atarax. The rash resolved.
Patient had redness and warmth on day after immune. 5-24-18 patient was seen in office for rash of Lt thigh with itching and color change. Patient was started on BENADRYL , BACTRIM, and prednisone at the 5-24-18 office visit. Patient returned to office on 6-4-18. Patient was seen for vomiting and fever and hives of bilateral arms and trunk of body. Redness warmth continued at site of injections and has now radiated around to the back of the leg. Patient was started on ZYRTEC.
This case was reported by a physician via sales rep and described the occurrence of pain in a 11-year-old female patient who received BEXSERO. On an unknown date, the patient received the 1st dose of BEXSERO. On an unknown date, less than a week after receiving BEXSERO, the patient experienced pain, induration and lymphadenopathy. On an unknown date, the outcome of the pain, induration and lymphadenopathy were recovered/resolved. the reporter considered the pain, induration and lymphadenopathy to be related to BEXSERO. Additional details were provided as follows: This case was previously reported to a doctor. the patient experienced pain and induration within two days of receiving the BEXSERO vaccine. She also developed lymphadenopathy after the other symptoms and all symptoms were resolved within 3 to 4 days. the field representative was unable to provide any further details.
This is a non serious spontaneous case from a consumer in the USA who reports experiencing post nasal drip (USA, Labelled). The reporter causality is not provided. This is a 43 year old female who experienced post nasal drip and cough approximately one week after receiving FluMist vaccine. The patient reported that the post nasal drip has been lessened but has been experiencing constant coughing and sore throat. Information from missing data report states all attempts to obtain follow-up have been unsuccessful. The patient will not give any information.
11/1/12 Wrong strength of Hep B vaccine given to patient. Adolescent dose instead of Adult strength. Pt. completed 2 dose of adult Hep B. Retired from company. Letter sent to encourage him to complete 3 dose on his own. 6/26/13.
Stomach pain, emesis, uncontrollable chills and headache. Temperature increased to 101.6 from normal over 2 hours despite TYLENOL.
Patient initially received the Janssen Covid-19 vaccine on 03/29/2021 and then received a booster dose  of Moderna 0.25 ml on 1/19/2022.  Patient contacted the pharmacy notifying us that he  got up to go to the bathroom  at approximately 3:00 am on the morning following his Moderna booster vaccine when he became dizzy and fell backwards into the bathtub.  From the fall, patient hit his head, had a broken tailbone, and has a subdural hematoma.  The patient reported that his subdural hematoma is progressively worse requiring hospitalization.
On 8/18 right thumb was swollen and sore, worse on 8/19 then left knee swollen and sore by 8/20 all joints were sore and tender. Went to MD. Was placed on Ibuprofen. Notified us on 8/25 and symptoms had resolved.
Parent states on phone that pt has fever, personality changes, and is yellow, 09/02/04.  Instructed to go to ER.  Mom stated felt personality changes started in pm on 08/27/04.
pt recvd vax;following 3rd dose, exp inc fatigue,n,v & jaundice; dph given by MD;pt reports feeling very tired; cannot work a full day
pt recvd vax & 48 hrs later quick onset t105 ax, vomiting, irritable-not consolable, poor appetite, diarrhea; 3MAY saw PA @ clinic poss vax react vs viral ailment;
The patient received infanrix on 8/26/21 in addition to Kinrix. Mother was notified of error per Dr and was informed of minimal rash or increased side effects. No effects from imm and stable child had a fever of 101.4 on 8/26/21 that responded to tylenol
2 days after the vaccine (on 2 May), I woke with an accelerated heart rate, chest pain, tightness of chest and shortness of breath.  I presented to MD where they took my vitals and an EKG.  The doctor called an ambulance for me as she assessed I was potentially displaying signs of pulmonary embolism.  The ambulance took me to the emergency department.  I ultimately stayed there two nights, and following many tests was diagnosed with acute pericarditis versus myopericarditis.  My admitting doctor and the cardiologist both advised that while they could not be 100% certain, the pericarditis could very well be an adverse reaction to the Moderna COVID-19 vaccine.  The admitting doctor told me she would report it as an adverse reaction. I am now on colchacine anti-inflammatory medication for 3 months and have one follow-up with the cardiologist to come.
This spontaneous report as received from a physician via company representative refers to six patients of unknown age and gender. On an unknown date, the patients were vaccinated with ZOSTAVAX (dose, frequency, route, lot # and expiration date were not provided). The physician mentioned that he used to send his patients to a pharmacy for immunization but he no longer did that because six of his patients, within a six month period on an unknown date, came down with shingles after receiving the ZOSTAVAX. Doctor asked an employee of the pharmacy what procedures were in place when there was a power outage and he was told they kept the freezer door closed. Doctor was assuming they did not have a generator that was why they just kept the door closed. The patient's sought unspecified medical attention. At the time of the report, the patient's status was unknown. Additional information has been requested.
Full body twitching, arms and feet numbness, ringing in ears, buzzing in body, lack of concentration
Began to develop hives on arms, then face and trunk. Eventually covered most of body in hives and rash. Over course of the next few days developed weakness in legs with some difficulty walking with pain.
Pfizer Bivalent; Drug start date: 18Nov2023; Pain at injection site, minor chills and fatigue; Pain at injection site, minor chills and fatigue; Pain at injection site, minor chills and fatigue; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 38-year-old male patient received bnt162b2, bnt162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 18Nov2023 as dose number unknown, single (Lot number: Unknown) at the age of 38 years, in right arm for covid-19 immunisation; influenza vaccine (INFLUENZA VACCINE), on 18Nov2023 as unk unk, single (Batch/Lot number: unknown), in left arm for immunisation. The patient didn't receive bnt162b2 omi xbb.1.5 (COMIRNATY (2023-2024 FORMULA)). The patient's relevant medical history included: "sulfa allergy" (unspecified if ongoing). The patient's concomitant medications were not reported. The following information was reported: VACCINATION SITE PAIN (non-serious) with onset 19Nov2023 at 03:00, outcome "recovering", CHILLS (non-serious), FATIGUE (non-serious) all with onset 19Nov2023 at 03:00, outcome "unknown" and all described as "Pain at injection site, minor chills and fatigue"; WRONG PRODUCT ADMINISTERED (non-serious), outcome "unknown", described as "Pfizer Bivalent; Drug start date: 18Nov2023". Therapeutic measures were not taken as a result of vaccination site pain. The information on the batch/lot number for bnt162b2, bnt162b2 omi ba.4-5, bnt162b2 omi xbb.1.5 has been requested and will be submitted if and when received.
This spontaneous report has been received from a medical assistant referring to a patient of unknown age and gender. Information about concomitant medication, pertinent medical history and drug reactions/allergies was not provided. On 05-DEC-2018, the patient was vaccinated with improperly stored RECOMBIVAX HB (lot # R001529, expiration date 07-NOV-2020) for prophylaxis (strength, dose detail, anatomical location and route of administration were not reported). No adverse effect was reported. The vaccine was exposed to temperature excursion between 0 degree Celsius (C) and 1 degree C for a time frame of 19 minutes and between 9 degree C and 25 degree C for 1 hour without previous temperature excursion. Data logger was involved. This is one of several reports received from the same reporter. Sender's Comments: US-009507513-1901USA001125.
This spontaneous report as received from a registered nurse refers to a patient of unknown age and gender. No concurrent conditions, medical history or allergy/drug reactions were reported. On 14-JAN-2016 the patient was vaccinated with GARDASIL lot # J009993 with expiry date 04-DEC-2015 (expired product administered). The dose number in the series of vaccination was unknown. No adverse effects were reported. There were no product quality complaints (PQC) involved. Additional information has been requested.
Started with itching of feet and ankles. 7:30 when undressed, red, pink, splotches. Medrol Pack ; Pepcid AC, Allegra.
COVID-19 Signs and Symptoms cough same; fever same (100-101); shortness of breath same (at night); headache same; sore throat same Contacts and Exposure No known exposure. Pt received 2nd COVID vaccine on Friday 6/11/21 Quality: dry cough Severity: moderate Duration: symptoms lasting 4 days Onset/Timing: date of symptoms onset: (Sunday 6/13/2021) Context: No history of asthma or pneumonia Associated Symptoms: no wheezing; no vomiting; no diarrhea; fatigue; runny nose ROS Patient reports loss of appetite, fever (101 here today), and diminished activity. He reports congestion and sore throat but reports no ear pain. He reports cough and difficulty breathing but reports no wheezing. He reports headache but reports no dizziness. He reports no nausea, no vomiting, and no diarrhea. He reports no sneezing and no runny nose.  Fever with cough, mild SOB, fatigue and pharyngitis, likely viral illness. Ibuprofen 400 mg given here now. Negative COVID test here today, will send for chest x-ray, lab work CBC (H/H, RBC, indices, WBC, plt) C-reactive protein comprehensive metabolic panel lyme disease Ab w/refl to blot (IgG, IgM), troponin I, sed rate by modified westergren. EKG done, Continue to monitor for increased WOB or any worsening of symptoms. Consult with Cardiology, Echo recommended and pt. scheduled for one.
On 1/5/2021 I started feeling like I got a cold. On 01/6/2021 I felt like I had sore throat, body millages & fever. On 01/7/2021 I tested positive for covid. Called my doctor on the 1/6/2021 & he recommended for me to go get tested for covid.
MILD REACTION; CHILLS; ON AND OFF FEVER; TIREDNESS; This spontaneous report received from a patient via a company representative concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, 1 total, administered on 10-MAR-2021 on an unspecified anatomical site for prophylactic vaccination. Batch number was not reported. Per procedure, no follow up will be requested for this case. No concomitant medications were reported. On MAR-2021, the subject experienced tiredness. On 11-MAR-2021 03:30, the subject experienced chills. On 11-MAR-2021 03:30, the subject experienced on and off fever. On an unspecified date, the subject experienced mild reaction. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from chills, and on and off fever on 11-MAR-2021, and tiredness on MAR-2021, and the outcome of mild reaction was not reported. This report was non-serious.
7/21/99 irritability & fever of 101; 7/22/99 seen by MD,Dx  viral illness; later that day had 5-8 episodes V; MD noted pt look dehydrated but not seriously ill; hosp for IV rehydration;bloody diarrhea;Barium Enema revealed Intussusception;
As reported by mother, the night of 1/3/13 around 10:45 PM patient started flailing arms and legs and eyes rolling up/back- which lasted about 3 minutes. She took her to ER. Patient did the same flailing for 2 days, stopped for a few days, then started again.  Mom states that she then took her to hospital on 1/14/13 where they did an EEG and was told she had slight seizure activity in both sides of brain. They also performed an MRI which was negative. Patient was admitted to hospital that night and Mother met with Neurologist on 1/15/13 mother stated that the doctor thinks the seizures were from the DTaP injection.  Patient was prescribed medication which she takes daily. Mother states the medication is Phenobarbitol 4mL q 12 hours.  Mother stated that they will keep her on the medication for 2 years then try to wean her off.
Document Type: ED Physician Progress Note   Document Subject: ED Progress Note   Performed By: PRIVATE on January 31, 2023 12:42   Verified By: PRIVATE MD on January 31, 2023 15:30    Encounter Info: Local Hospital, Inpatient, 01/31/23 -     * Final Report *        Basic Information  Time Seen: PRIVATE, MD / 01/31/2023 11:52  Chief Complaint  Abdominal pain (Complaint of), Vomiting (Complaint of)  History of Present Illness     Pt seen: 01/31/23 12:41:22 A 33 year old female presents to the ED via private vehicle c/o upper right abdominal pain onset 0530 this morning. Pt describes as sharp. She reports a few hours after her pain began she had 1 episod
day after injection-woke with  bad headache, bad  body aches, and chills, fatigue slept from 5pm  until 7 am today 2nd day- Still have a headache but body aches seem gone
Numbness of face mostly eyes and head; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (Numbness of face mostly eyes and head) in a 41-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 05-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-May-2021, the patient experienced HYPOAESTHESIA (Numbness of face mostly eyes and head). On 07-May-2021, HYPOAESTHESIA (Numbness of face mostly eyes and head) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were provided. No treatment details were provided.
Fever around 40 degrees Celsius for 24 hours, chills, headache, strong sweating, general weakness of the body. After a day, lower-grade fever (38 degrees Celsius for the next day and 37 degrees later on) and general body weakness for the next 5 days.
Vaccine leaked out of barrel of syringe onto the floor during administration. Patient did not receive at least half of the dose so the dose (0.5ml) was repeated.
Arthralgia Narrative: Developed left hand arthralgia about a week after the injection, which persisted for about a two and a half weeks. Vaccination was completed in the right deltoid and employee is right hand dominant. Arthralgia described as intermittent, achy, occasionally waked him at night while sleeping, reproducible with palpation. No prior trauma or h/o recent repetitive motion. No associated erythema, swelling, loss of function or other s/sx of adverse effects. Not therapies applies or tried.
She had some mild symptoms 1-2 days after the vaccine that resolved. 4-5 days after the vaccine she developed a headache, describes it as constant. She has taken tylenol and advil OTC without much relief. She denies any vision changes, worse with position changes, nausea or vomiting. Today is is improved without intervention, but still present mildly.
The patient received a full pediatric dose of the Pfizer orange cap instead of the adult dose of Pfizer purple cap, recommended for their age.
This spontaneous report was received from a pharmacist regarding a patient of unknown age and gender. Information on the concurrent condition, medical history and pertinent drug allergies of the patient were not reported. On 16-NOV-2015 at time- 08:55, the patient was vaccinated with improperly stored RECOMBIVAX HB lot # L016427 (expiry date, dose #, route, dose units and anatomical location were not specified). Concomitant medication was not reported. No adverse events were reported. The high temperature and low temperature at which the product was stored were 4.1 and 2.3 (units unspecified) respectively. There were no Product Quality Complaint (PQC) involved. This is one of several reports received from same reporter. Additional information has been requested.
102 Degrees Farenheit fever; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (102 Degrees Farenheit fever) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013120A and 013C20A) for COVID-19 vaccination.     Concurrent medical conditions included Allergy (Patient had allergies to almost Everything), Peanut allergy, Shellfish allergy and Asthma. Concomitant products included FEXOFENADINE HYDROCHLORIDE (ALLEGRA ALLERGY), PREGABALIN (LYRICA), MONTELUKAST SODIUM (SINGULAIR) and XYLOMETAZOLINE HYDROCHLORIDE (NASAL SPRAY II) for Allergy, METOPROLOL and AMLODIPINE from February 2022 to an unknown date for Blood pressure, IBUPROFEN (ADVIL ARTHRITIS PAIN) for Pain, HCTZ for Swelling.   On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced PYREXIA (102 Degrees Farenheit fever). The patient was treated with PARACETAMOL (TYLENOL [PARACETAMOL]) ongoing since an unknown date for Pain, at a dose of 500 milligram once a day. At the time of the report, PYREXIA (102 Degrees Farenheit fever) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Body temperature: 102 degrees fahrenheit (High) 102 Degrees Fahrenheit.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   This case was linked to MOD-2022-540261 (Patient Link).
have limited use in my L hand; numbness down the L side of my body into my L foot; experiencing a major flare-up of my condition; low-grade fever (between 99-100); severe muscle & joint pain; severe muscle & joint pain; existing nerve impingement affecting the left (L) side of my body & both sides of my face; decreased concentration & executive functioning; GI upset; anticipated some inflammation response to the vaccine; feel sick; This is a spontaneous report from a contactable other-HCP (patient). A 41-year-old non-pregnant female patient received the first dose bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number: EK9231), via an unspecified route of administration on 30Dec2020 at 18:00 at single dose in right arm for covid-19 immunization.  Medical history included Ehlers-Danlos syndrome hypermobility type, IgA deficiency, cervical radiculopathy, spondylosis of cervical region, chronic hypertension, fibromyalgia, androgenic alopecia, seasonal allergies, and known allergies: gold, nickel. The patient's concomitant medications were not reported. The patient previously took prednisone and experienced allergies. The patient reported that she anticipated some inflammation response to the vaccine from 04Jan2021. Briefly, she started to feel sick around 04Jan2021, by 10Jan2021 was experiencing a major flare-up of her condition requiring additional medication and time off from work. She had had a low-grade fever (between 99-100) from 04Jan2021 for 7 days, severe muscle and joint pain from 04Jan2021. She had existing nerve impingement affecting the left (L) side of her body and both sides of her face from 04Jan2021. Beginning 12Jan2021 she had limited use in her L hand, numbness down the L side of her body into her L foot. This was most likely due to significantly increased levels of inflammation as a result of the vaccine. She had also had GI upset, decreased concentration & executive functioning from 04Jan2021. It was unknown if the patient received treatment for the events. The outcome of the events was not resolved. The events resulted in doctor or other healthcare professional office/clinic visit.